Background The posttranscriptional modifications of transfer RNA (tRNA) are critical for all
aspects of the tRNA function and have been implicated in the tumourigenesis and …

Simple Summary Urinary bladder cancer is one of the ten major cancers worldwide, with
higher incidences in males, in smokers, and in highly industrialized countries. New …

Bladder cancer is a lethal malignancy and a majority of bladder cancer arise from urothelial
cells. Infiltration and metastasis are barriers for the radical cystectomy to achieve favored …

Background Patients with metastatic bladder cancer have very poor prognosis and
predictive biomarkers are urgently needed for early clinical detection and intervention. In this …

Bladder cancer (BCa) is one of the most common malignancies worldwide. Although
multiple efforts have been made, the 5‐year survival rate of patients with BCa remains …

Histologically, bladder cancer is a heterogeneous group comprising urothelial carcinoma
(UC), squamous cell carcinoma, adenocarcinomas (ACs), urachal carcinomas (UrCs), and …

Globally, bladder cancer (BLCA) is still the leading cause of death in patients with tumors.
The function and underlying mechanism of MTX-211, an EFGR and PI3K kinase inhibitor …

Background Bladder cancer (BLCA) is one of the most common malignancies worldwide.
One of the main reasons for the unsatisfactory management of BLCA is the complex …

Background Cancer is a heterogeneous disease in which tumor genes cooperate as well as
adapt and evolve to the changing conditions for individual patients. It is a meaningful task to …

Bladder pathologies, very common in the aged population, have a considerable negative
impact on quality of life. Novel targets are needed to design drugs and combinations to treat …